Table 4.

Characteristics of recurrent cases.

No.	Sex	Age	Relapse-free interval	Dose of relapse	Postrelapse treatment	References
1	M	75	3 months	Below 10 mg/d	Prednisolone 15 mg/d	[6]
2	M	70	8 years	5 mg/d	Prednisolone 30 mg/d	[25]
3	M	43	12 months	7.5 mg/d	Not described	[31]
4	M	57	4 months	Not described	Rituximab	[38]
5	M	56	7 months	Below 7.5 mg/d	Prednisolone 40 mg/d	[45]